Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1989; 13:1534-1539
© 1989 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gottlieb, S.
Right arrow Articles by Packer, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottlieb, S.
Right arrow Articles by Packer, M

Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure

SS Gottlieb, ML Kukin, D Ahern, and M Packer

Department of Medicine, Mount Sinai School of Medicine, City University of New York, New York.

Several circulating neurohormones have been shown to have prognostic significance in patients with chronic heart failure, but the relation between plasma levels of atrial natriuretic peptide and mortality in this disorder remains unknown. Plasma levels of immunoreactive atrial natriuretic peptide were measured in 102 patients in whom left ventricular ejection fraction, ventricular arrhythmias on ambulatory electrocardiographic recording and plasma levels of norepinephrine, renin activity, aldosterone and arginine vasopressin were also measured. Compared with patients with atrial natriuretic peptide concentrations below the median value of 125 pg/ml, patients with higher levels of the peptide had a higher plasma renin activity (8.9 +/- 1.8 versus 2.6 +/- 0.4 ng/ml per h) and plasma norepinephrine (858 +/- 116 versus 538 +/- 45 pg/ml), more frequent premature ventricular depolarizations (4,485 +/- 715 versus 2,004 +/- 495/day) and more advanced hemodynamic abnormalities (all p less than 0.05). During the subsequent 13 to 25 months of follow-up, patients with high levels of atrial natriuretic peptide had a significantly lower rate of survival than did those whose initial circulating peptide concentrations were normal or mildly increased (p = 0.01). These data indicate that, in patients with chronic heart failure, plasma atrial natriuretic peptide provides important prognostic information. This may relate to the ability of the hormone to reflect the interplay of several pathophysiologic factors that contribute to mortality in this disease.


This article has been cited by other articles:


Home page
Eur Heart JHome page
M. Huelsmann, S. Neuhold, G. Strunk, D. Moertl, R. Berger, R. Prager, H. Abrahamian, M. Riedl, R. Pacher, A. Luger, et al.
NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus
Eur. Heart J., September 2, 2008; 29(18): 2259 - 2264.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. B. Suliman, K. E. Welty-Wolf, M. Carraway, L. Tatro, and C. A. Piantadosi
Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis
Cardiovasc Res, November 1, 2004; 64(2): 279 - 288.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. L. Tran, X. Lu, M. Lei, Q. Feng, and Q. Wu
Upregulation of corin gene expression in hypertrophic cardiomyocytes and failing myocardium
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1625 - H1631.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
L. Menezes Falcao, F. Pinto, L. Ravara, and P. A. van Zwieten
BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2004; 5(3): 121 - 129.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Rodeheffer
Measuring plasma B-type natriuretic peptide in heart failure: Good to go in 2004?
J. Am. Coll. Cardiol., August 18, 2004; 44(4): 740 - 749.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. P. van den Berg, I. C. van Gelder, and D. J. van Veldhuisen
Depletion of atrial natriuretic peptide during longstanding atrial fibrillation
Europace, January 1, 2004; 6(5): 433 - 437.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Ohuchi, H. Takasugi, H. Ohashi, Y. Okada, O. Yamada, Y. Ono, T. Yagihara, and S. Echigo
Stratification of Pediatric Heart Failure on the Basis of Neurohormonal and Cardiac Autonomic Nervous Activities in Patients With Congenital Heart Disease
Circulation, November 11, 2003; 108(19): 2368 - 2376.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
U. Elkayam, M. W. Akhter, P. Tummala, S. Khan, and H. Singh
Nesiritide: A New Drug for the Treatment of Decompensated Heart Failure
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2002; 7(3): 181 - 194.
[Abstract] [PDF]


Home page
CirculationHome page
A. P. Bolger, R. Sharma, W. Li, M. Leenarts, P. R. Kalra, M. Kemp, A. J.S. Coats, S. D. Anker, and M. A. Gatzoulis
Neurohormonal Activation and the Chronic Heart Failure Syndrome in Adults With Congenital Heart Disease
Circulation, July 2, 2002; 106(1): 92 - 99.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Hulsmann, R. Berger, B. Sturm, A. Bojic, W. Woloszczuk, J. Bergler-Klein, and R. Pacher
Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure
Eur. Heart J., June 1, 2002; 23(11): 886 - 891.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Wu, W. Yan, J. Pan, J. Morser, and Q. Wu
Processing of Pro-atrial Natriuretic Peptide by Corin in Cardiac Myocytes
J. Biol. Chem., May 3, 2002; 277(19): 16900 - 16905.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. S. Anand, V. G. Florea, and L. Fisher
Surrogate end points in heart failure
J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1414 - 1421.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. Imazio, M. Bobbio, F. Broglio, A. Benso, V. Podio, M.R. Valetto, G. Bisi, E. Ghigo, and G.P. Trevi
GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy
Eur J Heart Fail, March 1, 2002; 4(2): 185 - 191.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, M. Hayashi, T. Tsutsui, M. Ohnishi, M. Fujii, T. Matsumoto, T. Yamamoto, et al.
Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy
J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1485 - 1490.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. T. Yan, T. D. Bradley, and P. P. Liu
The Role of Continuous Positive Airway Pressure in the Treatment of Congestive Heart Failure
Chest, November 1, 2001; 120(5): 1675 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
C. Zugck, C. Kruger, R. Kell, S. Korber, D. Schellberg, W. Kubler, and M. Haass
Risk stratification in middle-aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model
Eur J Heart Fail, October 1, 2001; 3(5): 577 - 585.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Boomsma and A. H. van den Meiracker
Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use
Cardiovasc Res, August 15, 2001; 51(3): 442 - 449.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. R Kalra, S. D Anker, and A. J.S Coats
Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin
Cardiovasc Res, August 15, 2001; 51(3): 495 - 509.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. G. Andreassi, S. Del Ry, C. Palmieri, A. Clerico, A. Biagini, and D. Giannessi
Up-regulation of 'clearance' receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones
Eur J Heart Fail, August 1, 2001; 3(4): 407 - 414.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, M. Hayashi, T. Tsutsui, M. Ohnishi, M. Sawaki, M. Fujii, T. Matsumoto, et al.
Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure
J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1228 - 1233.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
G. A Sagnella
Practical implications of current natriuretic peptide research
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 304 - 315.
[PDF]


Home page
J Am Coll CardiolHome page
K. Maeda, T. Tsutamoto, A. Wada, N. Mabuchi, M. Hayashi, T. Tsutsui, M. Ohnishi, M. Sawaki, M. Fujii, T. Matsumoto, et al.
High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure
J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1587 - 1593.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M. R COWIE
BNP: soon to become a routine measure in the care of patients with heart failure?
Heart, June 1, 2000; 83(6): 617 - 618.
[Full Text]


Home page
J Am Coll CardiolHome page
T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, M. Hayashi, T. Tsutsui, M. Ohnishi, M. Sawaki, M. Fujii, T. Matsumoto, et al.
Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure
J. Am. Coll. Cardiol., March 1, 2000; 35(3): 714 - 721.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Yamada, M. Fukunami, T. Shimonagata, K. Kumagai, H. Ogita, Y. Asano, A. Hirata, M. Hori, and N. Hoki
Prediction of paroxysmal atrial fibrillation in patients with congestive heart failure: a prospective study
J. Am. Coll. Cardiol., February 1, 2000; 35(2): 405 - 413.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. E. Lohmeier, H. L. Mizelle, G. A. Reinhart, and J.-P. Montani
Influence of angiotensin on the early progression of heart failure
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2000; 278(1): R74 - R86.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. Tsutamoto, A. Wada, K. Maeda, T. Hisanaga, N. Mabuchi, M. Hayashi, M. Ohnishi, M. Sawaki, M. Fujii, H. Horie, et al.
Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1
Eur. Heart J., December 2, 1999; 20(24): 1799 - 1807.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
R. W. Braith, M. A. Welsch, M. S. Feigenbaum, H. A. Kluess, and C. J. Pepine
Neuroendocrine activation in heart failure is modified by endurance exercise training
J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1170 - 1175.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
S. D. Anker and M. Rauchhaus
Heart failure as a metabolic problem
Eur J Heart Fail, June 1, 1999; 1(2): 127 - 131.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Hulsmann, B. Stanek, B. Frey, B. Sturm, D. Putz, T. Kos, R. Berger, W. Woloszczuk, G. Maurer, and R. Pacher
Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure
J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1695 - 1700.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
E. R. Levin, D. G. Gardner, and W. K. Samson
Natriuretic Peptides
N. Engl. J. Med., July 30, 1998; 339(5): 321 - 328.
[Full Text] [PDF]


Home page
HeartHome page
D. R Murdoch, J. Byrne, J. J Morton, T. A McDonagh, S. D Robb, S. Clements, I. Ford, J. J V McMurray, and H. J Dargie
Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice
Heart, December 1, 1997; 78(6): 594 - 597.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Neubauer, M. Horn, M. Cramer, K. Harre, J. B. Newell, W. Peters, T. Pabst, G. Ertl, D. Hahn, J. S. Ingwall, et al.
Myocardial Phosphocreatine-to-ATP Ratio Is a Predictor of Mortality in Patients With Dilated Cardiomyopathy
Circulation, October 7, 1997; 96(7): 2190 - 2196.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Tsutamoto, A. Wada, K. Maeda, T. Hisanaga, Y. Maeda, D. Fukai, M. Ohnishi, Y. Sugimoto, and M. Kinoshita
Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure : Prognostic Role of Plasma Brain Natriuretic Peptide Concentration in Patients With Chronic Symptomatic Left Ventricular Dysfunction
Circulation, July 15, 1997; 96(2): 509 - 516.
[Abstract] [Full Text]


Home page
CirculationHome page
T. De Marco and L. Goldman
Predicting Outcomes in Severe Heart Failure
Circulation, June 17, 1997; 95(12): 2597 - 2599.
[Full Text]


Home page
CirculationHome page
K. D. Aaronson, J. S. Schwartz, T.-M. Chen, K.-L. Wong, J. E. Goin, and D. M. Mancini
Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation
Circulation, June 17, 1997; 95(12): 2660 - 2667.
[Abstract] [Full Text]


Home page
CirculationHome page
C. R. Benedict, B. Shelton, D. E. Johnstone, G. Francis, B. Greenberg, M. Konstam, J. L. Probstfield, and S. Yusuf
Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular Dysfunction
Circulation, August 15, 1996; 94(4): 690 - 697.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Omland, A. Aakvaag, V. V. S. Bonarjee, K. Caidahl, R. T. Lie, D. W. T. Nilsen, J. A. Sundsfjord, and K. Dickstein
Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial Infarction : Comparison With Plasma Atrial Natriuretic Peptide and N-Terminal Proatrial Natriuretic Peptide
Circulation, June 1, 1996; 93(11): 1963 - 1969.
[Abstract] [Full Text]


Home page
CirculationHome page
K. B. James, P. M. McCarthy, S. Jaalouk, E. L. Bravo, A. Betkowski, J. D. Thomas, S. Nakatani, and F. M. Fouad-Tarazi
Plasma Volume and Its Regulatory Factors in Congestive Heart Failure After Implantation of Long-term Left Ventricular Assist Devices
Circulation, April 15, 1996; 93(8): 1515 - 1519.
[Abstract] [Full Text]


Home page
CirculationHome page
K. B. James, P. M. McCarthy, J. D. Thomas, R. Vargo, R. E. Hobbs, S. Sapp, and E. Bravo
Effect of the Implantable Left Ventricular Assist Device on Neuroendocrine Activation in Heart Failure
Circulation, November 1, 1995; 92(9): 191 - 195.
[Abstract] [Full Text]


Home page
CirculationHome page
G. Iervasi, A. Clerico, S. Berti, A. Pilo, A. Biagini, R. Bianchi, and L. Donato
Altered Tissue Degradation and Distribution of Atrial Natriuretic Peptide in Patients With Idiopathic Dilated Cardiomyopathy and Its Relationship With Clinical Severity of the Disease and Sodium Handling
Circulation, April 1, 1995; 91(7): 2018 - 2027.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
P. R. Marantz, J. N. Tobin, S. Wassertheil-Smoller, C. Ahn, R. M. Steingart, and J. P. Wexler
Prognosis in Ischemic Heart Disease: Can You Tell as Much at the Bedside as in the Nuclear Laboratory?
Arch Intern Med, December 1, 1992; 152(12): 2433 - 2437.
[Abstract] [PDF]


Home page
JAMAHome page
K. M. Davis, L. C. Fish, D. Elahi, B. A. Clark, and K. L. Minaker
Atrial Natriuretic Peptide Levels in the Prediction of Congestive Heart Failure Risk in Frail Elderly
JAMA, May 20, 1992; 267(19): 2625 - 2629.
[Abstract] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement